MEDIFAST INC - Common Stock, $0.001 par value per share (MED)

Historical Holders from Q1 2014 to Q3 2025

Symbol
MED on NYSE
Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
10,915,750
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
9,245,739
Holdings value
$126,369,373
% of all portfolios
0%
Number of holders
119
Number of buys
62
Number of sells
-41
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of MEDIFAST INC - Common Stock, $0.001 par value per share (MED)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RENAISSANCE TECHNOLOGIES LLC 8.09% -12.3% $11,182,714 -$1,475,408 888,928 -11.7% Renaissance Technologies LLC 02 Jan 2025
SUSQUEHANNA SECURITIES, LLC 6% -17.1% $8,953,098 -$1,786,136 654,945 -16.6% G1 Execution Services, LLC 30 Sep 2025
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 5.41% $8,136,534 595,211 CHARLES SCHWAB INVESTMENT MANAGEMENT INC 30 Sep 2025

Institutional Holders of MEDIFAST INC - Common Stock, $0.001 par value per share (MED)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 9,245,739 $126,369,373 +$8,375,184 $13.67 119
2025 Q2 8,622,468 $121,151,406 +$5,639,293 $14.05 119
2025 Q1 8,243,161 $111,111,582 -$12,305,056 $13.48 122
2024 Q4 8,923,034 $157,184,942 -$4,774,951 $17.62 129
2024 Q3 9,163,523 $175,430,199 -$26,787,069 $19.14 139
2024 Q2 10,429,064 $227,557,862 -$54,011,494 $21.82 157
2024 Q1 11,481,133 $439,976,756 +$30,953,025 $38.32 184
2023 Q4 10,327,821 $694,235,115 +$41,374,328 $67.22 216
2023 Q3 9,665,221 $724,203,937 -$8,659,421 $74.85 222
2023 Q2 9,669,541 $891,905,428 -$61,913,795 $92.16 234
2023 Q1 10,234,973 $1,061,341,644 +$86,814,952 $103.67 261
2022 Q4 9,414,287 $1,086,305,314 -$11,929,284 $115.35 273
2022 Q3 9,527,598 $1,033,430,006 -$59,199,848 $108.36 246
2022 Q2 9,687,197 $1,748,984,608 -$24,539,021 $180.51 271
2022 Q1 9,926,997 $1,697,651,687 +$16,771,177 $170.78 279
2021 Q4 9,781,823 $2,049,223,135 -$47,927,471 $209.43 293
2021 Q3 9,994,460 $1,926,341,111 -$26,844,446 $192.64 289
2021 Q2 9,961,273 $2,819,353,209 +$76,744,435 $282.98 294
2021 Q1 9,730,211 $2,062,202,677 -$49,579,570 $211.82 270
2020 Q4 9,997,947 $1,963,691,126 -$25,626,899 $196.34 255
2020 Q3 10,066,415 $1,655,403,260 -$331,394,781 $164.45 237
2020 Q2 12,151,352 $1,686,977,900 -$24,806,617 $138.77 220
2020 Q1 12,405,204 $775,864,757 -$71,958,765 $62.5 190
2019 Q4 13,341,998 $1,462,137,580 +$25,649,006 $109.58 209
2019 Q3 13,115,010 $1,359,220,679 +$134,209,752 $103.63 230
2019 Q2 11,639,821 $1,493,368,630 -$14,451,830 $128.3 245
2019 Q1 11,949,873 $1,524,491,311 +$80,136,864 $127.55 241
2018 Q4 11,332,591 $1,416,825,601 +$13,249,777 $125.02 239
2018 Q3 10,915,798 $2,418,264,368 +$107,291,483 $221.55 264
2018 Q2 10,540,926 $1,688,047,820 -$6,397,458 $160.16 247
2018 Q1 10,696,673 $999,579,447 +$28,445,651 $93.45 215
2017 Q4 10,541,541 $736,004,385 +$10,019,965 $69.81 195
2017 Q3 10,368,391 $615,586,479 -$10,696,658 $59.37 165
2017 Q2 10,674,565 $442,607,533 -$12,702,804 $41.47 158
2017 Q1 10,952,220 $485,943,663 +$77,724,218 $44.37 165
2016 Q4 10,518,697 $437,949,757 +$8,331,885 $41.63 157
2016 Q3 10,288,329 $388,816,493 +$4,897,796 $37.79 160
2016 Q2 10,205,167 $339,543,317 +$2,078,456 $33.27 150
2016 Q1 10,258,523 $309,648,499 +$18,127,439 $30.19 129
2015 Q4 9,653,092 $293,250,573 +$9,871,857 $30.38 125
2015 Q3 9,369,604 $252,983,267 -$24,553,155 $26.86 118
2015 Q2 10,156,513 $328,257,218 -$6,679,410 $32.32 126
2015 Q1 10,408,665 $312,157,083 +$3,842,904 $29.97 124
2014 Q4 10,275,587 $344,694,982 -$1,239,537 $33.55 123
2014 Q3 10,225,521 $335,728,325 -$69,009,124 $32.83 123
2014 Q2 12,485,516 $379,487,294 -$4,634,681 $30.41 129
2014 Q1 12,644,042 $368,081,892 +$28,114,069 $29.09 128